Literature DB >> 23719186

Metabolism-epigenome crosstalk in physiology and diseases.

Shinjiro Hino1, Katsuya Nagaoka, Mitsuyoshi Nakao.   

Abstract

The way in which energy is used in cells is determined under the influence of environmental factors such as nutritional availability. Metabolic adaptation is mainly achieved through the modulation of metabolic gene expression, and may also involve epigenetic mechanisms that enable long-term regulation. Recent studies have identified that nutrients and their metabolites exert an important influence on the epigenome, as they serve as substrates and/or coenzymes for epigenetic-modifying enzymes. Some epigenetic factors have been shown to regulate metabolic genes leading to a shift in energy flow. These findings suggest the concept of metabolism-epigenome crosstalk that may contribute to the formation of a long-term metabolic phenotype. This is particularly relevant to the pathogenesis of obesity and associated metabolic disorders, in which pre- and post-natal nutritional conditions affect disease risks in adulthood. Moreover, most cancer cells exploit metabolic pathways for their hyperproliferative activity, while metabolic misregulation leads to aberrant epigenetic regulation in some cancers. This review explores the possible mechanisms of metabolism-epigenome crosstalk that may facilitate our understanding of physiology and diseases.

Entities:  

Mesh:

Year:  2013        PMID: 23719186     DOI: 10.1038/jhg.2013.57

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  13 in total

1.  Lysine-specific demethylase 2 suppresses lipid influx and metabolism in hepatic cells.

Authors:  Katsuya Nagaoka; Shinjiro Hino; Akihisa Sakamoto; Kotaro Anan; Ryuta Takase; Takashi Umehara; Shigeyuki Yokoyama; Yutaka Sasaki; Mitsuyoshi Nakao
Journal:  Mol Cell Biol       Date:  2015-01-26       Impact factor: 4.272

Review 2.  Trained Innate Immunity and Its Implications for Mucosal Immunity and Inflammation.

Authors:  George Hajishengallis; Xiaofei Li; Ioannis Mitroulis; Triantafyllos Chavakis
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

3.  Retinoblastoma protein promotes oxidative phosphorylation through upregulation of glycolytic genes in oncogene-induced senescent cells.

Authors:  Shin-Ichiro Takebayashi; Hiroshi Tanaka; Shinjiro Hino; Yuko Nakatsu; Tomoka Igata; Akihisa Sakamoto; Masashi Narita; Mitsuyoshi Nakao
Journal:  Aging Cell       Date:  2015-05-25       Impact factor: 9.304

4.  Sensing risk, fearing uncertainty: systems science approach to change.

Authors:  Ivo P Janecka
Journal:  Front Comput Neurosci       Date:  2014-03-31       Impact factor: 2.380

5.  Rate of entropy model for irreversible processes in living systems.

Authors:  R Zivieri; N Pacini; G Finocchio; M Carpentieri
Journal:  Sci Rep       Date:  2017-08-22       Impact factor: 4.379

6.  Altered intracellular signaling by imatinib increases the anti-cancer effects of tyrosine kinase inhibitors in chronic myelogenous leukemia cells.

Authors:  Takuya Hirao; Masashi Yamaguchi; Megumi Kikuya; Hiroji Chibana; Kousei Ito; Shigeki Aoki
Journal:  Cancer Sci       Date:  2017-12-07       Impact factor: 6.716

7.  Computational modeling of methionine cycle-based metabolism and DNA methylation and the implications for anti-cancer drug response prediction.

Authors:  Mengying Zhang; Christian Saad; Lien Le; Kathrin Halfter; Bernhard Bauer; Ulrich R Mansmann; Jian Li
Journal:  Oncotarget       Date:  2018-02-21

Review 8.  Research Perspectives on the Regulation and Physiological Functions of FGF21 and its Association with NAFLD.

Authors:  Takeshi Inagaki
Journal:  Front Endocrinol (Lausanne)       Date:  2015-09-23       Impact factor: 5.555

Review 9.  Histone demethylase LSD1 controls the phenotypic plasticity of cancer cells.

Authors:  Shinjiro Hino; Kensaku Kohrogi; Mitsuyoshi Nakao
Journal:  Cancer Sci       Date:  2016-09-01       Impact factor: 6.716

10.  Serine Metabolism Supports the Methionine Cycle and DNA/RNA Methylation through De Novo ATP Synthesis in Cancer Cells.

Authors:  Oliver D K Maddocks; Christiaan F Labuschagne; Peter D Adams; Karen H Vousden
Journal:  Mol Cell       Date:  2016-01-07       Impact factor: 17.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.